BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35599927)

  • 1. The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation.
    Iv AA; Koprowski MA; Nabavizadeh N; Tsikitis VL
    Ann Gastroenterol; 2022; 35(3):226-233. PubMed ID: 35599927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the treatment of locally advanced rectal cancer.
    Ali F; Keshinro A; Weiser MR
    Ann Gastroenterol Surg; 2021 Jan; 5(1):32-38. PubMed ID: 33532678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
    BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
    Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
    Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locally advanced rectal cancer: Preliminary results of rectal preservation after neoadjuvant chemoradiotherapy.
    Vaccaro CA; Yazyi FJ; Ojra Quintana G; Santino JP; Sardi ME; Beder D; Tognelli J; Bonadeo F; Lastiri JM; Rossi GL
    Cir Esp; 2016 May; 94(5):274-9. PubMed ID: 26980259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

  • 8. Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?
    Fernandez LM; Figueiredo NL; Habr-Gama A; São Julião GP; Vieira P; Vailati BB; Nasir I; Parés O; Santiago I; Castillo-Martin M; Carvalho C; Parvaiz A; Perez RO
    Dis Colon Rectum; 2020 Aug; 63(8):1053-1062. PubMed ID: 32692070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
    Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
    Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?
    Glynne-Jones R; Grainger J; Harrison M; Ostler P; Makris A
    Br J Cancer; 2006 Feb; 94(3):363-71. PubMed ID: 16465172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latest evidence on the management of early-stage and locally advanced rectal cancer: a narrative review.
    Prabhakaran S; Yang TWW; Johnson N; Bell S; Chin M; Simpson P; Carne P; Farmer C; Skinner S; Warrier SK; Kong JC
    ANZ J Surg; 2022 Mar; 92(3):365-372. PubMed ID: 35001464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving role of neoadjuvant therapy in rectal cancer.
    Schrag D
    Curr Treat Options Oncol; 2013 Sep; 14(3):350-64. PubMed ID: 23828092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolving Field of Neoadjuvant Therapy in Locally-advanced Rectal Cancer: Evidence and Prospects.
    Ominelli J; Valadão M; Araujo ROC; Cristina de Melo A; Araujo LH
    Clin Colorectal Cancer; 2021 Dec; 20(4):288-298. PubMed ID: 34340916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
    Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer.
    Papaccio F; Roselló S; Huerta M; Gambardella V; Tarazona N; Fleitas T; Roda D; Cervantes A
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33287114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study.
    Hupkens BJP; Martens MH; Stoot JH; Berbee M; Melenhorst J; Beets-Tan RG; Beets GL; Breukink SO
    Dis Colon Rectum; 2017 Oct; 60(10):1032-1040. PubMed ID: 28891846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of radiotherapy in watch and wait strategy after neoadjuvant trerapy for rectal cancer].
    Wang YQ; Zhang Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):252-257. PubMed ID: 32192304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer].
    Fan J; Zhu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):527-533. PubMed ID: 31238633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Watch and Wait" for complete clinical response after neoadjuvant chemoradiotherapy for rectal cancer.
    Peacock O; Chang GJ
    Minerva Chir; 2019 Dec; 74(6):481-495. PubMed ID: 31580047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.